作者:
Elizabeth,Schepke [1]
;
Maja,Löfgren [2]
;
Torsten,Pietsch [2]
;
Thomas,Olsson Bontell [3]
;
Teresia,Kling [4]
;
Anna,Wenger [5]
;
Sandra,Ferreyra Vega [2]
;
Anna,Danielsson [2]
;
Sandor,Dosa [2]
;
Stefan,Holm [6]
;
Anders,Öberg [2]
;
Per,Nyman [5]
;
Marie,Eliasson-Hofvander [7]
;
Per-Erik,Sandström [8]
;
Stefan M,Pfister [9]
;
Birgitta,Lannering [10]
;
Magnus,Sabel [11]
;
Helena,Carén [12]
作者单位:
Childhood Cancer Centre, Queen Silvia Children's Hospital, Sahlgrenska University Hospital, Gothenburg, Sweden.
[1]
Sahlgrenska Centre for Cancer Research, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
[2]
Department of Neuropathology, DGNN Brain Tumour Reference Centre, University of Bonn Medical Centre, Bonn, Germany.
[3]
Department of Clinical Pathology and Cytology, Sahlgrenska University Hospital, Gothenburg, Sweden.
[4]
Department of Physiology, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
[5]
Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden.
[6]
Department of Paediatrics, Karolinska University Hospital, Stockholm, Sweden.
[7]
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
[8]
Department of Paediatrics, Linköping University, Linköping, Sweden.
[9]
Department of Paediatric Oncology and Haematology, Lund University, Skane University Hospital, Lund, Sweden.
[10]
Department of Paediatrics, Umeå University, Umeå, Sweden.
[11]
Department of Paediatric Haematology and Oncology, Heidelberg University Hospital, Heidelberg, Germany.
[12]
Division of Paediatric Neuro-oncology, German Cancer Research Centre (DKFZ), Heidelberg, Germany.
[13]
Department of Paediatrics, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
[14]
DOI
10.1111/nan.12838
PMID
35892159
发布时间
2022-10-15